gemfibrozil has been researched along with oxyntomodulin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Fu, J; Han, J; Li, C; Yang, Q; Yin, J; Zhou, F | 1 |
1 other study(ies) available for gemfibrozil and oxyntomodulin
Article | Year |
---|---|
Rational design and biological evaluation of gemfibrozil modified Xenopus GLP-1 derivatives as long-acting hypoglycemic agents.
Topics: Albumins; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Development; Gemfibrozil; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Tolerance Test; HEK293 Cells; Humans; Hypoglycemic Agents; Liraglutide; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Rats, Sprague-Dawley; Xenopus laevis | 2020 |